Trending stocks today
Owens & Minor (OMI-N)
NYSE:OMI
12.12
0.23
(1.93%) 1d
Financials
Technical Analysis
This summary was created by AI, based on 1 opinions in the last 12 months.
Owens & Minor (OMI-N) is a top pick in the smallcap health sector according to experts. The company made significant gains during the Covid pandemic by participating in the PPP program, and has since expanded its presence by acquiring two companies in the home healthcare industry. Despite a decline in PPP, the company experienced a 24% increase in sales in 2023 and has projected an annual EPS growth of 20%. Overall, the company is viewed favorably by experts for its performance and potential for future growth.
$26.880
Unknown
- «
- ‹
- 1
- ›
- »
Owens & Minor(OMI-N) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 1
Owens & Minor(OMI-N) Frequently Asked Questions
What is Owens & Minor stock symbol?
Owens & Minor is a American stock, trading under the symbol OMI-N on the New York Stock Exchange (OMI). It is usually referred to as NYSE:OMI or OMI-N
Is Owens & Minor a buy or a sell?
In the last year, 1 stock analyst published opinions about OMI-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Owens & Minor.
Is Owens & Minor a good investment or a top pick?
Owens & Minor was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Owens & Minor.
Why is Owens & Minor stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Owens & Minor worth watching?
In the last year, there was no coverage of Owens & Minor published on Stockchase.
What is Owens & Minor stock price?
On 2024-11-21, Owens & Minor (OMI-N) stock closed at a price of $12.12.
A top pick in smallcap health. They made PPP during Covid then bought two companies in home healthcare. Sales rose 24% in 2023, though PPP declined. They just projected EPS growing 20% annually.